skip to primary navigationskip to content

Petagene secure $2.1 Million in Funding 

last modified Jan 03, 2019 03:07 PM
2019 is off to a great start for the Petagene team who have been awarded $2.1 million in additional funding. The latest round was lead by U.S. venture firm Romulus Capital, with collaboration from other unnamed investors in London and Silicon Valley, bringing the total funding awarded to $3.2 million.

Based at ideaSpace West, Petagene, who develop compression software for large genomic data sets, secured the latest funding after landing a large contract with a pharmaceutical company. The funding will allow Petagene to expand its technical team in Cambridge, its global sales force, and further expand product offerings.

“As whole genome sequencing becomes more and more commonplace, the amount of data it creates places great strain on infrastructure. We help organisations with managing that data,” says PetaGene co-founder Dan Greenfield. “Through our compression technology, we make that data up to ten times smaller and faster to transfer for research and analysis, democratising precision medicine in the process”.

Find out more here.

RSS Feed Latest news

ideaSpace Vacancy - Community and Office Manager (Maternity cover)

Oct 03, 2019

ideaSpace are looking for an Operations and Office Manager (part time and maternity cover) based at ideaSpace West in the Hauser Forum. The closing date for applications is 17th October 2019 at 5pm.

LESSONS FROM A FOUNDER: Getting the Basics Right For Your Startup

Sep 27, 2019

Every business will experience failures - some misfires will be part of the process but others could spell disaster for your startup. Experienced founder and angel investor, Matthew Cleevely, recently hosted our Basics of Building a Business event and invited along three professionals he considers to be integral to the growth of his business. Here he discusses how their support has helped his company, 10to8, build the foundations for success and how others can avoid organisational, environmental and strategic failure.

View all news